Crossmark

Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: implications for clinical practice and future investigations

Crossref DOI link: https://doi.org/10.1186/s13054-020-03273-y

Published Online: 2020-09-16

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Flaczyk, Adam

Rosovsky, Rachel P.

Reed, Clay T.

Bankhead-Kendall, Brittany K.

Bittner, Edward A.

Chang, Marvin G. http://orcid.org/0000-0001-7126-2612
License Information

Text and Data Mining valid from 2020-09-16

Version of Record valid from 2020-09-16
More Information

Article History

Received: 17 August 2020

Accepted: 2 September 2020

First Online: 16 September 2020

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: RR is on the Board of Directors for the Pulmonary Embolism Response Team (PERT) Consortium and has no other competing interests as it relates to this manuscript. All other authors declare to have no competing interests.

Document is current

Any future updates will be listed below